Abstract
Summary
According to our LPI (LP Information) latest study, the global Oral Vaccines market size was valued at US$ 2420.2 million in 2023. With growing demand in downstream market, the Oral Vaccines is forecast to a readjusted size of US$ 3284.9 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Oral Vaccines market. Oral Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Vaccines market.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
Key Features:
The report on Oral Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Vaccines market. It may include historical data, market segmentation by Type (e.g., Rotavirus Vaccine, Cholera Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Vaccines industry. This include advancements in Oral Vaccines technology, Oral Vaccines new entrants, Oral Vaccines new investment, and other innovations that are shaping the future of Oral Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Vaccines market.
Market Segmentation:
Oral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segmentation by application
Public
Private
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Vaccines market?
What factors are driving Oral Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Vaccines market opportunities vary by end market size?
How does Oral Vaccines break out type, application?
The research report highlights the growth potential of the global Oral Vaccines market. Oral Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Vaccines market.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
Key Features:
The report on Oral Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Vaccines market. It may include historical data, market segmentation by Type (e.g., Rotavirus Vaccine, Cholera Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Vaccines industry. This include advancements in Oral Vaccines technology, Oral Vaccines new entrants, Oral Vaccines new investment, and other innovations that are shaping the future of Oral Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Vaccines market.
Market Segmentation:
Oral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segmentation by application
Public
Private
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Vaccines market?
What factors are driving Oral Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Vaccines market opportunities vary by end market size?
How does Oral Vaccines break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Oral Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.3 Oral Vaccines Sales by Type
2.3.1 Global Oral Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Vaccines Sale Price by Type (2019-2024)
2.4 Oral Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Vaccines Sales by Application
2.5.1 Global Oral Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Vaccines Sale Price by Application (2019-2024)
3 Global Oral Vaccines by Company
3.1 Global Oral Vaccines Breakdown Data by Company
3.1.1 Global Oral Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Oral Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Oral Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Vaccines Revenue by Company (2019-2024)
3.2.2 Global Oral Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Oral Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Vaccines Product Location Distribution
3.4.2 Players Oral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Vaccines by Geographic Region
4.1 World Historic Oral Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Vaccines Sales Growth
4.4 APAC Oral Vaccines Sales Growth
4.5 Europe Oral Vaccines Sales Growth
4.6 Middle East & Africa Oral Vaccines Sales Growth
5 Americas
5.1 Americas Oral Vaccines Sales by Country
5.1.1 Americas Oral Vaccines Sales by Country (2019-2024)
5.1.2 Americas Oral Vaccines Revenue by Country (2019-2024)
5.2 Americas Oral Vaccines Sales by Type
5.3 Americas Oral Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Vaccines Sales by Region
6.1.1 APAC Oral Vaccines Sales by Region (2019-2024)
6.1.2 APAC Oral Vaccines Revenue by Region (2019-2024)
6.2 APAC Oral Vaccines Sales by Type
6.3 APAC Oral Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Vaccines by Country
7.1.1 Europe Oral Vaccines Sales by Country (2019-2024)
7.1.2 Europe Oral Vaccines Revenue by Country (2019-2024)
7.2 Europe Oral Vaccines Sales by Type
7.3 Europe Oral Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Vaccines by Country
8.1.1 Middle East & Africa Oral Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Vaccines Sales by Type
8.3 Middle East & Africa Oral Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Vaccines
10.3 Manufacturing Process Analysis of Oral Vaccines
10.4 Industry Chain Structure of Oral Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Vaccines Distributors
11.3 Oral Vaccines Customer
12 World Forecast Review for Oral Vaccines by Geographic Region
12.1 Global Oral Vaccines Market Size Forecast by Region
12.1.1 Global Oral Vaccines Forecast by Region (2025-2030)
12.1.2 Global Oral Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Vaccines Forecast by Type
12.7 Global Oral Vaccines Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Oral Vaccines Product Portfolios and Specifications
13.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Vaccines Product Portfolios and Specifications
13.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Oral Vaccines Product Portfolios and Specifications
13.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Oral Vaccines Product Portfolios and Specifications
13.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Oral Vaccines Product Portfolios and Specifications
13.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Oral Vaccines Product Portfolios and Specifications
13.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Oral Vaccines Product Portfolios and Specifications
13.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Oral Vaccines Product Portfolios and Specifications
13.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Oral Vaccines Product Portfolios and Specifications
13.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Oral Vaccines Product Portfolios and Specifications
13.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Oral Vaccines Product Portfolios and Specifications
13.12.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Oral Vaccines Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Oral Vaccines Product Portfolios and Specifications
13.14.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion